Xtant Medical Holdings Inc XTNT
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2010-06-30 |
| Shares Out. | 140,260,000 |
| Website | xtantmedical.com/ ↗ |
| Phone | 14063880480 |
| Employees | 151 |
| Revenue | $20.9M |
| Gross Profit | $12.0M |
| Net Income | -$3.1M |
| Free Cash Flow | $7.8M |
| Total Assets | $78.0M |
| Total Liabilities | $29.4M |
| Equity | $48.6M |
About Xtant Medical Holdings Inc
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Xtant Medical Holdings Inc is a publicly traded company under the ticker symbol XTNT on the NYSE MKT LLC, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)